Generic name for cialis

ATR-FTIR characterization of generic brand-named and counterfeit sildenafil- and tadalafil-based tablets found on the Brazilian market.
Viagra and Cialis are among the most counterfeited medicines in many parts of the world, including Brazil. Despite the many studies that have been made regarding discrimination between genuine and counterfeit samples, most published works do not contemplate generic and similar versions of these medicines and also do not explore excipients/adjuvants contributions when characterizing genuine and suspected samples. In this study, we present our findings in exploring ATR-FTIR spectral profiles for characterizing both genuine and questioned samples of several generic and brand-name sildenafil- and tadalafil-based tablets available on the Brazilian market, including Viagra and Cialis. Multi-component spectral matching (deconvolution), objective visual comparison and correlation tests were used during analysis. Besides from allowing simple and quick identification of counterfeits, results obtained evidenced the strong spectral similarities between generic and brand-named tablets employing the same active ingredient and the indistinguishability between samples produced by the same manufacturer, generic or not. For all sildenafil-based and some tadalafil-based tablets tested, differentiation between samples from different manufacturers, attributed to slight variations in excipients/adjuvants proportions, was achieved, thus allowing the possibility of tracing an unknown/unidentified tablet back to a specific manufacturer.
Keywords: Cialis; Excipients; Generic medicine; Manufacturer identification; Spectral deconvolution; Viagra.
Copyright © 2017 The Chartered Society of Forensic Sciences. Published by Elsevier B.V. All rights reserved.
Similar articles.
Dos Santos MK, de Cassia Mariotti K, Kahmann A, Anzanello MJ, Ferrão MF, de Araújo Gomes A, Limberger RP, Ortiz RS. Dos Santos MK, et al. J Pharm Biomed Anal. 2019 Mar 20;166:304-309. doi: 10.1016/j.jpba.2019.01.029. Epub 2019 Jan 17. J Pharm Biomed Anal. 2019. PMID: 30685655.
Custers D, Vandemoortele S, Bothy JL, De Beer JO, Courselle P, Apers S, Deconinck E. Custers D, et al. Drug Test Anal. 2016 Mar-Apr;8(3-4):378-87. doi: 10.1002/dta.1813. Epub 2015 May 28. Drug Test Anal. 2016. PMID: 26033891.
Spálovská D, Pekárek T, Kuchař M, Setnička V. Spálovská D, et al. J Pharm Biomed Anal. 2021 Nov 30;206:114383. doi: 10.1016/j.jpba.2021.114383. Epub 2021 Sep 20. J Pharm Biomed Anal. 2021. PMID: 34587570.
Brito JBG, Bucco GB, John DK, Ferrão MF, Ortiz RS, Mariotti KC, Anzanello MJ. Brito JBG, et al. Forensic Sci Int. 2020 Apr;309:110191. doi: 10.1016/j.forsciint.2020.110191. Epub 2020 Feb 10. Forensic Sci Int. 2020. PMID: 32092622 Review.
Patel DN, Li L, Kee CL, Ge X, Low MY, Koh HL. Patel DN, et al. J Pharm Biomed Anal. 2014 Jan;87:176-90. doi: 10.1016/j.jpba.2013.04.037. Epub 2013 May 6. J Pharm Biomed Anal. 2014. PMID: 23721687 Review.
Cited by.
Sansone A, Cuzin B, Jannini EA. Sansone A, et al. Sex Med. 2021 Dec;9(6):100437. doi: 10.1016/j.esxm.2021.100437. Epub 2021 Oct 4. Sex Med. 2021. PMID: 34619517 Free PMC article. Review.
Salim MR, Widodo RT, Noordin MI. Salim MR, et al. Polymers (Basel). 2021 Jun 30;13(13):2185. doi: 10.3390/polym13132185. Polymers (Basel). 2021. PMID: 34209331 Free PMC article.
Ouranidis A, Tsiaxerli A, Vardaka E, Markopoulou CK, Zacharis CK, Nicolaou I, Hatzichristou D, Haidich AB, Kostomitsopoulos N, Kachrimanis K. Ouranidis A, et al. Pharmaceuticals (Basel). 2021 Apr 15;14(4):365. doi: 10.3390/ph14040365. Pharmaceuticals (Basel). 2021. PMID: 33920975 Free PMC article. Review.
MeSH terms.